Solve Therapeutics
Clinical trials sponsored by Solve Therapeutics, explained in plain language.
-
New drug SLV-154 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called SLV-154 in about 70 people with advanced solid tumors (like head and neck, lung, breast, or ovarian cancer) that have spread. The main goal is to find a safe dose and check for side effects. Researchers will also watch for any signs …
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for advanced cancer? SLV-324 enters first human trial
Disease control Recruiting nowThis early-stage trial tests a new drug called SLV-324 in about 70 people with metastatic solid tumors that have worsened after standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look at how the drug moves through the body …
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC